Effects of <i>Lactobacillus reuteri</i>-containing lozenges on healing after surgical removal of mandibular third molars:a randomised controlled trial by Wälivaara, D.-Å. et al.
u n i ve r s i t y  o f  co pe n h ag e n  
Københavns Universitet
Effects of Lactobacillus reuteri-containing lozenges on healing after surgical removal
of mandibular third molars
Wälivaara, D.-Å.; Sjögren, I.; Gerasimcik, N.; Yucel-Lindberg, T.; Twetman, S.; Abrahamsson,
P.
Published in:
Beneficial Microbes
DOI:
10.3920/BM2018.0168
Publication date:
2019
Document version
Publisher's PDF, also known as Version of record
Document license:
CC BY-NC-ND
Citation for published version (APA):
Wälivaara, D. -Å., Sjögren, I., Gerasimcik, N., Yucel-Lindberg, T., Twetman, S., & Abrahamsson, P. (2019).
Effects of Lactobacillus reuteri-containing lozenges on healing after surgical removal of mandibular third molars:
a randomised controlled trial. Beneficial Microbes, 10(6), 653-659. https://doi.org/10.3920/BM2018.0168
Download date: 03. Feb. 2020
Beneficial Microbes, 2019; 10(6): 653-659 
Wageningen Academic 
P u b l i s h e r s
ISSN 1876-2883 print, ISSN 1876-2891 online, DOI 10.3920/BM2018.0168 653
1. Introduction
There is emerging evidence that the intake of probiotic 
bacteria may have beneficial effects on oral health (Twetman 
et al., 2017). Typically, various lactobacilli strains have 
been suggested as adjunct to ‘good clinical practice’ for the 
prevention and management of childhood caries (Jørgensen 
et al., 2016), gingivitis and periodontal disease (Gruner et 
al., 2016), candidiasis (Kraft-Bodi et al., 2015) and halitosis 
(Keller et al., 2012). It has also been suggested that beneficial 
bacteria may improve surgical wound healing through 
a systemic influence on the immune response (Huseini 
et al., 2012; Jones et al., 2012; Peral et al., 2009; Tsiouris 
et al., 2017) and via up-regulation of the neuropeptide 
hormone oxcytocin (Poutahidis et al., 2013). We have 
previously shown that supernatants of Lactobacillus reuteri 
can stimulate the production of PGE2 by human gingival 
fibroblasts in the presence of interluekin-1β, and thereby 
possibly accelerate wound healing (Castiblanco et al., 2017). 
Furthermore, we noted a tendency to improved healing of 
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Abstract
We investigated the effect of probiotic supplements on oral wound healing, swelling, pain and discomfort after 
surgical removal of mandibular third molars. A second aim was to evaluate if the intervention could influence the 
concentrations of oxytocin in saliva. Sixty-four consecutive volunteers (18-34 years) were enrolled to a double-blind 
randomised placebo-controlled trial with two parallel arms. Following surgery, the patients were asked to take three 
lozenges per day containing two strains of Lactobacillus reuteri (DSM 17938 and ATCC PTA 5289) or placebo 
for two weeks. The clinical healing and extra-oral swelling were scored two weeks post-operatively. Samples of 
wound exudate were cultivated for the presence of Staphylococcus aureus and β-haemolytic streptococci. Salivary 
oxytocin concentrations were analysed from pre- and post-surgery samples using ELISA technique. Compliance 
and the subjective perception of swelling, pain and discomfort were reported daily through visual analogue scales 
in a logbook. All patients except three completed the protocol and the postoperative course was uneventful in most 
cases. Minor extra-oral swellings were noted in five patients, but none required antibiotic treatment. At the 2-week 
follow-up, there were no significant differences in clinical wound healing index, extra-oral swelling, bacterial growth 
or salivary oxytocin levels between the groups. The self-reported data unveiled, however, a significantly reduced 
sense of swelling, in particular during the second week after surgery in the probiotic test group (P<0.05). Likewise, 
significantly fewer nights with disturbed sleep and fewer days with sick-leave from work were reported among 
the participants in the test group (P<0.05). No differences were found in the post-operative use of analgesics. In 
conclusion, we found no significant influence of probiotic supplements on objective wound healing after surgical 
extraction of impacted mandibular third molars. However, since the patients’ perceived significant post-operative 
ameliorations, further studies are needed to explore the patient’s value of the intervention.
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standardised oral wounds (punch biopsies) during intake 
of L. reuteri supplements (Twetman et al., 2018). Most 
oral wounds are, however, open sockets, following surgical 
extractions of teeth. The primary aim of this study was 
therefore to investigate the effect of probiotic supplements 
on oral wound healing, swelling, pain and discomfort after 
surgical removal of mandibular third molars. A second 
aim was to evaluate if the intervention could influence 
the local bacterial growth in the wound exudate and 
the postoperative concentrations of oxytocin in saliva. 
The null hypothesis was that the wound healing or the 
perceived swelling, pain and discomfort would not differ 
from exposure to placebo.
2. Materials and methods
Subjects
The study was carried out between March 2016 and April 
2018 at the Oral and Maxillofacial Surgery Department, 
Halland Hospital in Halmstad, Sweden. Sixty-four 
consecutive patients (33 females, 31 males) referred for 
removal of a lower third molar accepted the invitation 
and were enrolled in the study. The mean age was 29.9 
years (range 18-34) and the inclusion criteria were (1) 
an impacted or partly impacted mandibular third molar 
with a history of pericoronitis; (2) uncompromised general 
health; (3) no regular medication (except contraceptives); 
(4) non-smoker; and (5) living within an area of 40 km from 
the hospital. Exclusion criteria were acute pericoronitis 
and when larger pathological conditions associated with 
the third molar were detected preoperatively. Eligible 
patients with regular intake of probiotic supplements prior 
treatment were not considered for inclusion. The patients 
received verbal and written information about the study 
prior to signing the consent form, including their right to 
end their participation at any time.
Study design and ethical approval
The study was designed as a single-centre randomised 
placebo-controlled clinical trial with two parallel arms. 
The project was ethically approved by the Regional Ethical 
Committee in Lund, Sweden (Dnr 2015/483) and registered 
in ClinicalTrials.gov NCT02572531.
Allocation procedure
After informed written consent, the patients were randomly 
allocated into two groups receiving either probiotic or 
placebo lozenges (Figure 1). The randomisation procedure 
was performed according to a randomisation table. The 
study was double blind and the lozenges were delivered 
in identical plastic containers which were separated by a 
colour code and the code was not unveiled until after the 
statistical analyses.
Pre-surgical examination and action
All mandibular third molars were clinically examined before 
surgery. 60% were located on the patient’s right side and 
40% on the left side. A standard orthopantomography 
was exposed, supplemented with cone-beam-computer-
tomography, when indicated. A sample of whole mixed 
saliva was collected through expectoration and stored 
frozen until further analyses.
Informed
consent
(n=64)
Test group
and surgery
(n=32) 
1-week follow-up
(n=13)
2-week follow-up
(n=30)
No show
(n=2)
Placebo group
and surgery
(n=32) 
1-week follow-up
(n=12)
2-week follow-up
(n=31)
No show
(n=1)
Figure 1. Flow-chart of study participants. Only the first 25 patients enrolled were recalled after 1 week.
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Surgical procedure
The surgical procedures were performed by six different 
maxillofacial surgeons in a standardised way. The operating 
field was anaesthetised with 5.4 ml 2% lidocaine with 
adrenaline. A full thickness mucoperiosteal buccal flap 
was raised in the region from the lower first molar to the 
third molar area. To expose the crown to the enamel-
cement junction of the lower third molar, an osteotomy 
was performed using a carbon round-bur with a speed of 
40,000 rpm. The tooth was then separated and removed. 
The flap was sutured with Vicryl® 4-0 sutures (Ethicon, 
Somerville, NJ, USA) after a thorough debridement and 
saline rinsing of the operated area. No additional wound 
dressing was applied.
Postoperative procedures and intervention
All patients were given standardised postoperative 
information with recommendations to rinse with 1% 
chlorhexidine solution two times per day and take analgesics 
(paracetamol 1 g ×4 and ibuprofen 400 mg ×3) for the 
next coming 5 days if and when needed. In addition, the 
participants were thoroughly instructed to take three 
lozenges per day containing either two strains of L. reuteri 
(DSM 17938 and ATCC PTA 5289, ProDentis®, BioGaia 
AB, Stockholm, Sweden) or placebo for 2 weeks. The active 
lozenges had at least 2×108 live bacteria of the combined 
strains per lozenge. The placebo lozenges had an identical 
colour, shape and taste, but without active bacteria. The 
subjects were told to take one lozenge in the morning, 
one at lunch time and one in the evening and let it slowly 
melt in the oral cavity during 5 min. The participants 
were also provided with a logbook in which the subjective 
swelling, pain and discomfort were scored with a continuous 
0-10 visual analogue scales (VAS) on a daily basis (0 = 
no swelling/pain/discomfort; 10 = maximum of swelling/
pain/discomfort). Moreover, the use of analgesics, or any 
other drugs, and any possible perceived side-effects were 
noted in the same logbook. The VAS were evaluated with 
a ruler to the nearest 0.5 centimetre. The compliance was 
also checked through the logbooks; it was considered as 
‘good’ when >80% of the lozenges were taken and ‘poor’ 
when <50% of the lozenges were consumed.
Follow-up
After 14 days, all patients were recalled for a review 
appointment in which the individual logbooks were 
collected. All remaining sutures were removed and the 
operating field was visually scored with respect to wound 
healing and possible postoperative infection according to 
5-point scale (Table 1) based on Landry et al. (1988). A 
second whole saliva sample was collected and kept frozen 
at -18 °C (255 K) until further analyses. From the wound 
area, a smear sample was collected with aid of sterile tops 
and transferred for immediate bacterial cultivation. The 
first 25 patients enrolled in the study were also recalled to 
a 1-week follow-up for a clinical assessment of the wound 
healing.
Biochemical and microbial analyses
After thawing, oxytocin levels, expressed as pg/ml, were 
measured using oxytocin ELISA kit (ab133050, Abcam, 
Cambridge, UK). All steps were followed as instructed by 
the manufacturer’s protocol and a 4-parameter analysis 
was used to analyse the results. The bacterial samples were 
investigated for the presence (growth vs non-growth) of 
Staphylococcus aureus and β-haemolytic streptococci 
(Streptococcus pyogenes and Streptococcus dysgalactiae). For 
S. aureus, a selective agar plate (Staph aureus CHROMagar) 
was used, in which the bacteria grow with pink colonies. 
The cultures were incubated at 36 °C (309 K) in aerobic 
conditions for 18-24 h. β-haemolytic streptococci were 
evaluated with aid of a two-layered non-selective blood 
agar plate (Oxoid, Basingstoke, UK) supplemented with 
3.5% horse-blood and 3.5% sheep-blood. The plates were 
incubated at 36 °C (309 K) in anaerobic conditions for 18-
24 h. The β-haemolytic colonies were further investigated 
with Streptococcal latex agglutination (Streptex; Remel 
Europe Ltd., Dartford, UK).
Table 1. Clinical healing index scores.
Healing score Wound characteristics
5 – excellent All wound area is pink; no bleeding on palpation; no granulation tissue; no connective tissue at incision margin.
4 – very good Less than one quarter of wound area is red, no bleeding on palpation, no granulation tissue; no connective tissue at incision 
margin.
3 – good Less than half of the wound area is red; no bleeding on palpation; no granulation tissue; no connective tissue at incision margin.
2 – poor More than half of the wound area is red; bleeding on palpation; granulation tissue evident; incision margin not epithelialised.
1 – very poor Two or more of the following features: More than half of the wound area is red; bleeding on palpation; granulation tissue evident; 
no epithelium at incision margin; infection present with suppuration.
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Statistical methods
All data were processed with the IBM SPSS software 
(version 23.0, Armonk, NY, USA). For continuous data, 
the follow-up values were compared to baseline within each 
group by Wilcoxon paired two-sided test and differences 
between groups are analysed by Wilcoxon unpaired test. 
Categorical scores were compared between groups with 
chi-square tests. P-values less than 0.05 were considered 
statistically significant. The sample size was estimated 
with aid of the MedCalc software (Ostend, Belgium) and it 
was anticipated that a 30% difference in healing, pain and 
discomfort would be of clinical importance. With α=0.05 
and β=0.2, the power calculation indicated that at least 30 
subjects were needed in each group to disclose a statistically 
significant difference between the groups.
3. Results
Clinical observations
Three patients dropped out from the protocol as they 
failed to show up for the 2-week examination and thus, no 
logbooks were received. The clinical healing was uneventful 
in most cases. Minor extra-oral swellings were noted in 
five patients, but none required antibiotic treatment. The 
distribution of the clinical healing index is shown in Table 2. 
At the 2-week follow-up, there were no differences between 
the groups. However, when the 25 patients that attended 
the 1-week were analysed separately, the distribution of the 
healing scores was in favour for the probiotic intervention 
group.
Biochemical and microbial evaluation
The pre- and post-treatment concentrations of salivary 
oxytocin are shown in Table 3. There were no significant 
differences between the groups and the levels remained 
also fairly stable within the groups, albeit a weak tendency 
of reduced concentrations was noted in the placebo group. 
Growth of S. aureus was detected in seven patients from 
the test group and six patients in the control group and 
presence of β-haemolytic streptococci was recorded in 
three and four patients, respectively.
Self-reported data and compliance
The self-reported perception of swelling, pain and 
discomfort are summarised in Table 4 and the data on 
fever, sleep, analgesics and sick-leave are shown in Table 5. 
There were no significant differences between the groups 
with few exceptions; the sense of swelling during the second 
week after surgery was significantly lower (P<0.05) in the 
probiotic test group as illustrated day-by-day in Figure 2. 
Likewise, significantly fewer nights with disturbed sleep 
and fewer days with sick leave from work (P<0.05) were 
reported among the participants of the test group (Table 
5). The compliance with the protocol was rated as good in 
Table 2. Distribution of clinical healing score after 1 and 2 weeks after the third-molar surgery.
Time and group Healing score (%)
1 2 3 4 5
1 week – test group (n=13) 15 23 31 31a –
1 week – placebo group (n=12) – 17 42 42 –
2 weeks – test group (n=30) – – 7 40 53
2 weeks – placebo group (n=31) – – 7 32 61
a Significant difference in distribution compared with placebo (chi-square-test, P<0.05).
Table 3. Salivary concentrations (pg/ml) of oxytocin at baseline and at the 2-week follow-up.1
Time Test group (n=30) Placebo group (n=31) P-value
Baseline 107.4 (24.3) 90.9 (15.6) 0.56 (NS)2
2-week follow-up 106.8 (22.5) 81.7 (16.6) 0.37 (NS)
Mean difference 0.7 (17.0) 9.3 (19.0) 0.61 (NS)
1 Values in the table denote mean and standard error.
2 NS = not statistically significant.
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Table 4. Self-reported swelling, pain and discomfort during the first and second week after third molar surgery.1
Time and group Swelling Pain Discomfort
1st week – test group (n=13) 19.4 (9.8) 25.0 (12.9) 23.0 (11.9)
1st week – placebo group (n=12) 23.9 (17.3) 26.1 (16.2 24.9 (16.2)
2nd week – test group (n=30) 2.8 (3.8)2 9.9 (12.3) 6.6 (7.9)
2nd week – placebo group (n=31) 8.9 (10.9) 12.3 (13.8) 10.0 (11.3)
1 Values in table are the mean cumulative values and standard deviations obtained from 0-10 visual analogue scales.
2 Statistically significant difference compared with placebo, independent sample t-test (P<0.05).
Table 5. Self-reported data on postoperative fever, sick-leave and consumption of analgesics.1
Measure Test group (n=30) Placebo group (n=31) P-value
Fever, yes (%) 79 83 0.69 (NS)2
Fever, number of days (mean, sd) 0.4 (0.9) 0.4 (0.9) 1.00 (NS)
Disturbed sleep, yes (%) 42 61 0.14 (NS)
Disturbed sleep, number of nights (mean, sd) 1.5 (2.4) 2.9 (2.8) <0.053
Analgesics 1st week, number of tablets (mean, sd) 34.0 (22.1) 39.3 (21.8) 0.35 (NS)
Analgesics 2nd week, number of tablets (mean, sd) 12.4 (18.6) 8.1 (13.4) 0.30 (NS)
Sick leave, number of days (mean, sd) 0.3 (0.5) 1.1 (1.5) <0.053
1 Values are percent or mean with standard deviations (sd).
2 NS = not statistically significant.
3 Statistically significant difference compared with placebo, independent sample t-test.
0
1
2
3
4
5
6
OP 1 2 3 4 5 6 7 8 9 10 11 12 13 14
VA
S 
sc
or
e
Days from surgery
Test Placebo
Figure 2. Patients’ day-by-day perception of oral swelling during the first two weeks after mandibular 3rd molar surgery with 
and without probiotic supplements. The values denote mean visual analogue scales (VAS) score (0-10). The maximal standard 
deviation was on day one (2.6) and the minimum on day 14 (0.2).
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over 70% of the patients in both groups. Poor compliance 
was found among 19% of the patients in the test group and 
11% in the placebo group.
4. Discussion
To our best knowledge, this is the first study in which 
the use of probiotics supplements has been evaluated in 
maxillofacial surgery. The reason to select L. reuteri was 
that one of the strains was isolated from the oral cavity and 
that this consumer product has proven beneficial effects on 
various oral conditions (Twetman et al., 2017). The main 
finding was that no significant difference in the clinical 
wound healing score was disclosed between the groups and 
that no major complications or secondary infections were 
present in neither of the groups. The null hypothesis could, 
however, not be completely rejected as some interesting 
results from the self-reported endpoints were obtained. 
The patients in the test group perceived less post-operative 
swelling and reported significantly less nights with affected 
sleep and fewer days with sick leave. Such perceived reliefs 
are certainly important and of value for the individual 
patient, but we found no specific pattern or correlations to 
gender or age. It was interesting to find that most patients 
followed the recommended intake of analgesics during the 
first week with an average of 7-8 tablets per day, although 
it was emphasised that the use should be restricted to the 
individual need. In contrast, only 47% of the patients used 
chlorhexidine rinses and they were equally distributed in 
the test and the placebo group. Notably, a ‘per protocol’ 
analysis based selectively on those with good compliance 
did not alter any of the results in a significant way.
There are a number of limitations to be considered. First 
of all, the clinical healing was scored two weeks after the 
operation and an earlier follow-up would probably have been 
more discriminating. In fact, a one-week examination was 
originally planned but this was pragmatically abandoned 
since the frequent recall-schedule was a severe obstacle in 
the enrolment process. Thus, only the first 25 patients were 
examined one week postoperatively and interestingly, a clear 
trend in favour for the probiotic supplements were seen. 
Second, the intervention was commenced in connection 
with the surgery and it is possible that an intake of probiotic 
supplements 1-2 weeks prior to surgery could have amended 
the results, as it may take some day to initiate the immune 
response. Third, the wound healing index applied here was 
originally suggested for periodontal surgery and has to our 
knowledge not previously been applied for mandibular third 
molar surgery. A fourth fact to consider is that the surgical 
procedure was carried out by a number of different oral 
surgeons and it is well known that the rate of success and 
failures can vary with the operators experience and skills 
(Del Fabbro and Taschieri, 2007). Furthermore, the use 
of chlorhexidine mouth rinses may have influenced the 
results. Since the use of such antibacterial is a recommended 
procedure after oral surgery, we had to retain the rinses in 
this project for ethical reasons as ‘best clinical practice’. On 
the other hand, the low compliance and equal distribution 
between the groups reduced the risk of bias. Finally, the 
self-reported data were for natural reasons not validated. 
The participants were strongly emphasised to fill in the 
logbook on a daily basis in order to minimise recall bias 
but partly incomplete data sets were seen in almost 40% of 
the questionnaires. The large inter-individual variations in 
the VAS scores reflected certainly considerable differences 
in the patient’s subjective perception of pain, swelling and 
discomfort.
The reason for analysing the growth of S. aureus and 
beta-haemolytic streptococci was that those species often 
are involved in wound infections and impaired healing 
(Hughes et al., 2009; Tong et al., 2015). Mirroring the non-
complicated clinical findings, we found a low prevalence 
in both groups. Furthermore, the patients with growth 
displayed low to moderate numbers of colony forming 
units and only one patient exhibited abundant growth of 
S. aureus. It should, therefore, be underlined that present 
findings cannot be generalised to the situation of chronic 
oral wounds often appearing among immunosuppressed 
patients and frail elderly. The non-affected concentrations 
of salivary oxytocin were not supportive to the study of 
Poutahidis and co-workers (2013), but in agreement with 
our previous pilot observations (Twetman et al., 2018).
5. Conclusions
Within the limitations of the present study, we found 
no significant influence of probiotic supplements on 
oral wound healing after surgical extraction of impacted 
mandibular third molars. The patients reported, however, 
less swelling during the second week after operation and 
fewer days with sick-leave and fewer nights with disturbed 
sleep. Further studies are however needed to further 
explore the patient’s perceived value of the intervention. 
In particular, more frequent follow-ups and an extended 
intervention, starting well ahead of the surgery, would be 
of interest.
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